Acticor Biotech R&D and Labs

Acticor Biotech is a biopharmaceutical company developing an innovative drug for the treatment in the acute phase of ischemic stroke.


Investors

Last Funding Type: Series B
Funding Status: Early Stage Venture
Headquarters: Paris, Ile-de-France, France
Founded Date: 2010-01-01
Last Funding Date: 2019-11-06
Total Funding: $33 202 489
Estimated Revenue: $1M to $10M